Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905148-25-001714
Filing Date
2025-05-15
Accepted
2025-05-15 15:19:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10192
2 jfa.htm EX-1 5931
  Complete submission text file 0000905148-25-001714.txt   17820
Mailing Address 855 BOYLSTON STREET 10TH FLOOR BOSTON MA 02116
Business Address 855 BOYLSTON STREET 10TH FLOOR BOSTON MA 02116 857-201-5983
K2 HealthVentures Equity Trust LLC (Filed by) CIK: 0001948604 (see all company filings)

EIN.: 842128131 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Subject) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94343 | Film No.: 25951875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)